Evidence map›Paper›PMID 42707357›Full record

ArticleCanadian journal of kidney health and disease2026

Implementing a Protocol for Incremental Hemodialysis in Incident Patients With Kidney Failure: A Quality Improvement Initiative.

Alexander Messina, Ali Taha, Alba Sanchez-Allakhverdieva, Noémie Laurier, Alexander Tom, Vicki Tan, Nancy Filteau, Jerrica McKinnon, Daniel Blum, Catherine Weber and 1 more

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander MessinaMcGill University, Montreal, PQ, Canada.
Ali TahaMcGill University, Montreal, PQ, Canada.
Alba Sanchez-AllakhverdievaMcGill University, Montreal, PQ, Canada.ORCID https://orcid.org/0009-0006-2849-6062
Noémie LaurierMcGill University, Montreal, PQ, Canada.ORCID https://orcid.org/0009-0004-1895-5179
Alexander TomDivision of Nephrology, McGill University Health Center, Montreal, PQ, Canada.
Vicki TanDivision of Nephrology, McGill University Health Center, Montreal, PQ, Canada.
Nancy FilteauDivision of Nephrology, Jewish General Hospital, Montreal, PQ, Canada.
Jerrica McKinnonDivision of Nephrology, McGill University Health Center, Montreal, PQ, Canada.
Daniel BlumDivision of Nephrology, Jewish General Hospital, Montreal, PQ, Canada.ORCID https://orcid.org/0000-0001-5742-0848
Catherine WeberDivision of Nephrology, McGill University Health Center, Montreal, PQ, Canada.ORCID https://orcid.org/0000-0002-2558-6904
Emilie TrinhDivision of Nephrology, McGill University Health Center, Montreal, PQ, Canada.ORCID https://orcid.org/0000-0001-8479-6656

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Incremental hemodialysis (iHD), which adapts dialysis frequency to a patient's residual kidney function, may ease the transition to dialysis, improve quality of life, and reduce costs. Objectives: In our tertiary care center, we aimed to develop and implement an iHD protocol and to safely initiate 75% of eligible patients starting incident dialysis on iHD, defined as twice-weekly dialysis, over a two-year period. This project was a nephrology fellow-led quality improvement (QI) initiative conducted as part of the Canadian Society of Nephrology's Quality Improvement and Implementation Science national curriculum. Methods: We conducted a QI study from November 1, 2022, to December 31, 2024. An iHD protocol was developed with input from key stakeholders. It included a patient information sheet, routine 24-hour urine collections, a nursing safety checklist integrated into the electronic medical record, and an alert system to identify patients on iHD for physician review. Patients were eligible for iHD if medically stable without indications for thrice-weekly dialysis, and able to comply with physician recommendations and complete required 24-hour urine collections. The primary outcome measure was the proportion of incident patients initiated on iHD. Balancing measures included reasons for iHD discontinuation, hospitalization and mortality rates, and duration on iHD, while process measures included completion rates of nursing checklists and urine collections. Results: Of 135 incident hemodialysis starts during the study period, 57 (42%) patients were deemed eligible for iHD, of which 44 (77%) were initiated on an incremental prescription (mean age 61 years). At the end of the study, 25% of patients remained on iHD, with a mean duration of 234 days on iHD. The most common reasons for transition to thrice-weekly hemodialysis were volume overload (54%) and inadequate clearance (33%). Five Plan-Do-Study-Act (PDSA) cycles led to refinements of the protocol, including increased frequency of nursing checklist, facilitated identification of patients on iHD, more frequent electrolyte monitoring, and multiple educational sessions with healthcare providers. Overall, the 24-hour urine collection completion rate by patients was 69%, while nursing checklist completion rates increased from 61% in the first 8 months to a 100% by study end. Mortality and dialysis-related hospitalization rates, excluding vascular access-related issues, were significantly lower in the incremental group than in the conventional group (mortality: 2.3% vs. 17.6%; hospitalization: 0.10 vs. 0.22 events per patient-year). Conclusion: A structured iHD protocol, refined through iterative PDSA cycles, enabled safe initiation of iHD in 77% of eligible patients in our center. This study illustrates how a systematic, QI-driven approach can guide other centers in adopting incremental HD safely while promoting ongoing process improvement and patient-centred care.

Indexed as

CKD (chronic kidney disease)ESRD (end-stage renal disease)hemodialysisprotocolquality improvement

Identifiers

PMID42707357
PMCPMC13547799

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.